Leadership Overview
Bristol-Myers Squibb has 10 executives leading key functions including technology engineering, strategic transformation, financial operations, process validation, and organizational governance.
Focused on advancing global biopharmaceutical innovation, Bristol-Myers Squibb delivers life-saving therapies for oncology and immunology while maintaining a commitment to rigorous scientific research and patient-centered medical breakthroughs.
Focused on advancing global biopharmaceutical innovation, Bristol-Myers Squibb delivers life-saving therapies for oncology and immunology while maintaining a commitment to rigorous scientific research and patient-centered medical breakthroughs.
Leadership Roles at Bristol-Myers Squibb
Brandon Taverni - Vice President, BD and Strategic Finance, Chief Financial Officer Support Lead
Brandon Taverni, the Vice President, BD and Strategic Finance, Chief Financial Officer Support Lead at Bristol-Myers Squibb, manages the financial architecture underpinning business development and long-term investment strategies. Overseeing capital allocation for research partnerships, the Vice President, BD and Strategic Finance, Chief Financial Officer Support Lead evaluates the fiscal viability of potential alliances that expand the company's therapeutic reach. This role involves providing critical financial analysis to the executive team to support informed decision-making regarding portfolio growth and asset acquisition. By optimizing financial structures, Brandon Taverni drives the fiscal health required to sustain intensive R&D efforts in oncology and chronic disease treatment. The Vice President, BD and Strategic Finance, Chief Financial Officer Support Lead collaborates with internal stakeholders to ensure that strategic financial planning aligns with the broader corporate mission. Through disciplined oversight of investment portfolios, Taverni secures the resources necessary for continuous innovation and global market expansion.
Tomas Bohman - Global Chief Financial Officer, Research & Senior VP, Development, Finance
Tomas Bohman, the Global Chief Financial Officer, Research & Senior VP, Development, Finance at Bristol-Myers Squibb, directs the financial strategy for the company's global research and development organization. Overseeing the budgeting and resource allocation for the entire R&D pipeline, the Global Chief Financial Officer, Research & Senior VP, Development, Finance ensures that capital is deployed effectively to support the discovery of new therapeutic breakthroughs. This role involves providing financial oversight for clinical development programs, ensuring that investments align with the company's long-term scientific goals. By managing the financial health of the R&D division, Tomas Bohman drives the sustainability of the company's innovation engine. The Global Chief Financial Officer, Research & Senior VP, Development, Finance collaborates with scientific leaders to evaluate the economic impact of new drug candidates and development strategies. Through disciplined financial management, Bohman secures the resources necessary to advance the company's mission of delivering transformative medicines to patients worldwide.
Benjamin Kingscott - Manager, Chief Technology Officer Plant Engineering
Benjamin Kingscott, the Manager, Chief Technology Officer Plant Engineering at Bristol-Myers Squibb, directs the technical infrastructure supporting large-scale pharmaceutical manufacturing. Overseeing complex facility systems, the Manager, Chief Technology Officer Plant Engineering ensures that production environments meet stringent global regulatory standards for drug synthesis. This role involves optimizing equipment reliability to maintain consistent output across the company's diverse medication portfolio. By integrating advanced automation into plant operations, Benjamin Kingscott drives efficiency gains that reduce downtime and accelerate the delivery of critical treatments to patients. The Manager, Chief Technology Officer Plant Engineering collaborates with cross-functional teams to implement sustainable engineering solutions that align with long-term manufacturing goals. Through meticulous oversight of plant assets, Kingscott secures the operational integrity required for high-volume production of oncology and cardiovascular therapies, ultimately supporting the broader mission of delivering innovative medical solutions to global markets.
Umang Srivastava - Strategy Director, Transformation & Gps Chief of Staff
Umang Srivastava, the Strategy Director, Transformation & Gps Chief of Staff at Bristol-Myers Squibb, architects the organizational frameworks necessary for executing complex biopharmaceutical business initiatives. Managing the alignment between global product strategy and operational execution, the Strategy Director, Transformation & Gps Chief of Staff facilitates communication across executive leadership to ensure cohesive progress on key development milestones. This role involves identifying opportunities for process optimization within the global supply chain to enhance patient access to essential medications. By synthesizing data-driven insights, Umang Srivastava drives strategic decision-making that strengthens the company's market position in virology and immunoscience. The Strategy Director, Transformation & Gps Chief of Staff coordinates high-level projects that translate scientific breakthroughs into scalable commercial realities. Through rigorous performance monitoring and resource allocation, Srivastava ensures that the organization remains agile in a competitive landscape, consistently delivering value through efficient operational transformation and strategic foresight.
Kimberly Kam - Senior Specialist, Chief Technology Officer MSAT Process Validation Engineer II
Kimberly Kam, the Senior Specialist, Chief Technology Officer MSAT Process Validation Engineer II at Bristol-Myers Squibb, executes the technical validation protocols essential for maintaining high-quality pharmaceutical manufacturing standards. Overseeing the rigorous testing of production processes, the Senior Specialist, Chief Technology Officer MSAT Process Validation Engineer II ensures that every therapeutic batch meets precise safety and efficacy requirements. This role involves analyzing manufacturing data to identify potential process improvements that enhance yield and consistency across the company's medication portfolio. By implementing advanced validation methodologies, Kimberly Kam drives the technical excellence required for the successful commercialization of complex cancer immunotherapies. The Senior Specialist, Chief Technology Officer MSAT Process Validation Engineer II works closely with engineering teams to troubleshoot production challenges and ensure compliance with international health regulations. Through meticulous attention to process integrity, Kam supports the reliable delivery of life-saving treatments to patients worldwide.
Nicole Costa - Cell Therapy Development & Operations Chief of Staff
Nicole Costa, the Cell Therapy Development & Operations Chief of Staff at Bristol-Myers Squibb, coordinates the operational workflows required to advance cutting-edge cell therapy programs. Managing the integration of research and manufacturing functions, the Cell Therapy Development & Operations Chief of Staff ensures that development timelines remain synchronized with commercial objectives. This role involves facilitating cross-departmental collaboration to overcome technical hurdles in the production of personalized medical treatments. By streamlining operational processes, Nicole Costa drives the efficiency needed to scale complex therapies for patients with serious unmet needs. The Cell Therapy Development & Operations Chief of Staff provides critical support to leadership by monitoring project progress and resource utilization across the cell therapy division. Through effective management of internal communications and strategic planning, Costa ensures that the organization maintains its leadership in the rapidly evolving field of immunotherapy, ultimately accelerating the path from scientific discovery to patient care.
Divya Sahdev - Senior Director, Governance and Portfolio Operations, GPS Chief of Staff
Divya Sahdev, the Senior Director, Governance and Portfolio Operations, GPS Chief of Staff at Bristol-Myers Squibb, directs the governance frameworks that oversee the company's extensive global product portfolio. Managing the operational oversight of development programs, the Senior Director, Governance and Portfolio Operations, GPS Chief of Staff ensures that all initiatives align with corporate strategic priorities and regulatory requirements. This role involves establishing clear accountability structures to optimize the performance of diverse therapeutic assets. By implementing robust governance processes, Divya Sahdev drives the organizational discipline necessary to manage complex research pipelines effectively. The Senior Director, Governance and Portfolio Operations, GPS Chief of Staff collaborates with senior leadership to refine portfolio strategies and allocate resources toward high-impact medical solutions. Through consistent monitoring of operational metrics, Sahdev ensures that the company maintains a balanced and productive pipeline, supporting the long-term delivery of innovative treatments to global patient populations.
Scott Trautwein - Manager, Chief Technology Officer MSAT Process Validation
Scott Trautwein, the Manager, Chief Technology Officer MSAT Process Validation at Bristol-Myers Squibb, leads the technical validation efforts for manufacturing processes within the company's global production network. Overseeing the validation of complex pharmaceutical synthesis, the Manager, Chief Technology Officer MSAT Process Validation ensures that all manufacturing systems operate within defined parameters to guarantee product quality. This role involves developing and executing validation strategies that support the introduction of new therapeutic products into the market. By applying deep technical expertise to process challenges, Scott Trautwein drives the reliability of manufacturing operations, ensuring that life-saving medications are produced consistently and safely. The Manager, Chief Technology Officer MSAT Process Validation collaborates with quality assurance and engineering teams to maintain compliance with global health standards. Through rigorous oversight of process validation activities, Trautwein secures the technical foundation necessary for the company's continued success in delivering advanced medical solutions to patients.
Brittany Schuck - Chief of Staff, ICV
Brittany Schuck, the Chief of Staff, ICV at Bristol-Myers Squibb, manages the strategic operations and executive communications for the Immunology, Cardiovascular, and Virology divisions. Overseeing the coordination of cross-functional teams, the Chief of Staff, ICV ensures that departmental goals remain aligned with the company's broader mission of addressing serious patient needs. This role involves facilitating high-level decision-making processes and managing the flow of critical information to leadership. By optimizing internal workflows, Brittany Schuck drives the operational efficiency required to advance the company's portfolio in these key therapeutic areas. The Chief of Staff, ICV supports the development of strategic plans that enhance the organization's impact on chronic disease management. Through effective project management and stakeholder engagement, Schuck ensures that the ICV division remains focused on delivering innovative treatments, ultimately contributing to the company's reputation for scientific excellence and commitment to improving patient outcomes.
John Esposito - Director, Office of Chief of Staff
John Esposito, the Director, Office of Chief of Staff at Bristol-Myers Squibb, manages the operational functions and strategic priorities of the executive office. Overseeing the coordination of high-level initiatives, the Director, Office of Chief of Staff ensures that the executive team remains focused on the company's core mission of biopharmaceutical innovation. This role involves facilitating communication between various departments to ensure that organizational objectives are met with precision and speed. By streamlining the operations of the executive office, John Esposito drives the efficiency required to manage a complex global organization. The Director, Office of Chief of Staff supports the development of strategic agendas that guide the company's response to evolving market needs and scientific opportunities. Through effective management of executive workflows and stakeholder relationships, Esposito ensures that the leadership team operates with the cohesion and clarity necessary to deliver meaningful therapeutic advances to patients across the globe.
Explore Leadership Teams in Manufacturing
Fresenius Kabi, a subsidiary of Fresenius, is a global health care company that specializes in medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is headquartered in Bad Homburg, Germany with locations around the world.
Company Leadership SM
AK
KL
Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science to improve people's lives through innovative healthcare solutions. The Swiss-based company operates through two primary divisions: Pharmaceuticals and Diagnostics, making it one of the few healthcare companies with leading positions in both areas. Roche's pharmaceutical division focuses on developing and manufacturing prescription medicines across major therapeutic areas including oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. The diagnostics division provides a comprehensive range of products and services for early detection, prevention, diagnosis, and management of diseases, spanning laboratory diagnostics, tissue diagnostics, and diabetes care. Roche is committed to personalized healthcare, pioneering the development of targeted therapies and companion diagnostics that enable treatment decisions tailored to individual patients. The company invests heavily in research and development, maintaining a robust pipeline of innovative medicines and diagnostic solutions while collaborating with academic institutions, biotechnology companies, and healthcare partners worldwide. Headquartered in Basel, Switzerland, Roche operates globally with a presence in numerous countries, employing a diverse workforce of scientists, researchers, healthcare professionals, and business experts dedicated to transforming patient care and making a meaningful difference in the fight against serious diseases.
Company Leadership TH
LA
RL
Md
AstraZeneca focuses on the discovery, development, and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca is based in the United Kingdom.
Company Leadership KO
JZ
Hetero is a global pharmaceutical company founded in 1993 and headquartered in India with operations across Asia, Europe, North America, South America, Africa, and the Middle East. The company specializes in manufacturing generic pharmaceuticals and is recognized as a major producer of anti-retroviral medications for HIV/AIDS treatment. Hetero develops and manufactures a wide range of pharmaceutical products while maintaining research facilities and production centers worldwide.
Company Leadership VS
KS
Frequently Asked Questions Regarding Bristol-Myers Squibb Top Executives and Leadership Team
Unlock more people and company data
